tm
Seeing Is Believing
tm
Seeing Is Believing
IBRX is currently covered by 2 analysts with an average price target of $7.72. This is a potential upside of $0.37 (5.03%) from yesterday's end of day stock price of $7.35.
Immunitybio's activity chart (see below) currently has 16 price targets and 16 ratings on display. The stock rating distribution of IBRX is 60% BUY and 40% HOLD.
Analysts average stock forecasts to be materialized ratio is 55.83% with an average time for these price targets to be met of 212.67 days.
Highest price target for IBRX is $5, Lowest price target is $5, average price target is $7.72.
Most recent stock forecast was given by JOSEPH CATANZARO from PIPER SANDLER on 25-Mar-2024. First documented stock forecast 16-May-2017.
Currently out of the existing stock ratings of IBRX, 3 are a BUY (60%), 2 are a HOLD (40%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
5
$0.18 (3.73%)
4
1 months 3 days ago
3/8 (37.5%)
$-0.44 (-8.09%)
135
Buy
5
$0.18 (3.73%)
8
11 months 13 days ago
1/2 (50%)
$1.78 (55.28%)
226
Sell
0.8
$-4.02 (-83.40%)
1.25
4 years 10 months 28 days ago
4/5 (80%)
$-0.23 (-22.33%)
277
What is IBRX (Immunitybio) average time for price targets to be met?
Which analyst has the current highest performing score on IBRX (Immunitybio) with a proven track record?
Which analyst has the current lower performing score on IBRX (Immunitybio) with a proven track record?
Which analyst has the most public recommendations on IBRX (Immunitybio)?
Which analyst is the currently most bullish on IBRX (Immunitybio)?
Which analyst is the currently most reserved on IBRX (Immunitybio)?
